Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 16

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 16
---
 analysts;                                                                          |

| · | increased difficulty in maintaining or obtaining financing on attractive 
 terms, or at all;                                                        |

| · | changes in interest rates; |

| · | changes in market valuations of similar companies; |

<div align='center'>S-8</div>

| · | changes in the regulatory environment in which our business operates; |

| · | additions or departures of key personnel; |

| · | actions by institutional stockholders; |

| · | speculation in the press or investment community; and |

| · | general market and economic conditions. |

Our Series B Preferred Stock is subordinate to our debt and other liabilities, and your interests could be diluted by the issuance of additional preferred stock and by other transactions.

As of September 30, 2025, our total gross
indebtedness to third parties was approximately $711.7 million, and our other liabilities were approximately $18.8 million. We may incur
significant additional debt to finance future acquisition activities as well as additional liabilities in operating our business. Our
Series B Preferred Stock is subordinate to all of our existing and future debt, including borrowings under our Credit Facility and
any indebtedness that we may incur in the future. Our existing debt restricts, and our future debt may include restrictions on, our ability
to pay dividends to preferred stockholders in the event of a default under the debt facilities.

Our charter provides that we may issue up to 10,000,000
shares of preferred stock, $0.001 par value per share. There are currently 3,105,000 shares of our Series A Preferred Stock outstanding.
The issuance of additional preferred stock on parity with or senior to our Series B Preferred Stock would dilute the interests of
the holders of our Series B Preferred Stock, and any issuance of preferred stock senior to our Series B Preferred Stock or of
additional indebtedness could affect our ability to pay dividends on, redeem or pay the liquidation preference on our Series B Preferred
Stock. If at any time we have failed to pay, on the applicable payment date, accrued dividends on any shares that rank in priority with
respect to dividends, we may not pay any dividends on the Series B Preferred Stock or redeem or otherwise repurchase any shares of
Series B Preferred Stock until we have paid or set aside for payment the full amount of the unpaid dividends on the shares that rank
in priority with respect to dividends that must, under the terms of such shares, be paid before we may pay dividends